跳至主要内容
临床试验/NCT00229528
NCT00229528已完成4 期

Dose Ranging Study of the Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease

University of Oklahoma2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2004年3月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
25
试验地点
2
主要终点
To define the percent COAT-platelet and response to Paxil-CR in 5 control subjects.

研究概览

简要总结

COAT-platelets stands for collagen and thrombin stimulated platelets, which are two things in the body that make platelets stick together. These platelets may be important in the initiation of a heart attack (myocardial infarction). A chemical in the body called serotonin maybe responsible for COAT-platelet production. Paroxetine causes a significant reduction in platelet serotonin and therefore may have value in preventing heart attacks. Therefore, the current study is designed to determine whether paroxetine will decrease COAT-platelet production in normal volunteers and patients with cardiovascular disease.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • normal volunteers (without heart disease)
  • patients with heart disease
  • between ages 18 & 65

排除标准

  • children less than 18 years
  • adults greater than 65 years
  • those who can not keep appointments
  • patients within 2 weeks of a coronary catheterization
  • patients within 6 months of unstable angina or myocardial infarction
  • individuals with allergies to paroxetine or similar medications
  • individuals having adverse events to paroxetine or similar medications
  • individuals with diagnosis of mania
  • individuals with a diagnosis of hypomania
  • individuals with a diagnosis of bipolar disorders
  • individuals with a diagnosis of depression
  • individuals with a diagnosis of panic disorders
  • individuals with a diagnosis of seizure disorders
  • individuals with a history of suicide attempts
  • individuals with a diagnosis of hyponatremia
  • individuals with active bleeding disorders
  • individuals with a diagnosis of narrow angle glaucoma
  • individuals with an estimated creatinine clearance of less that 30 ml/min
  • individuals taking potentially interacting medications

结局指标

主要结局

To define the percent COAT-platelet and response to Paxil-CR in 5 control subjects.

次要结局

  • To define the percent COAT-platelet and response to Paxil-CR in 20 patients with Coronary Artery Disease.

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验